Jurgi Camblong
Founder at SOPHIA GENETICS SA
Net worth: 12 M $ as of 30/05/2024
Profile
Jurgi Camblong is the founder of SOPHiA GENETICS SA, which was founded in 2011.
He is currently the Chairman of Agora Care SA and the Director of Swiss Biotech Association.
Dr. Camblong was the Chief Executive Officer of Gene Predictis SA from 2010 to 2011.
He was also an Associate at the University of Oxford and the University of Geneva.
Dr. Camblong holds an MBA from École Polytechnique Fédérale de Lausanne and a doctorate from the University of Geneva.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
SOPHIA GENETICS SA
3.76% | 14/02/2024 | 2,460,081 ( 3.76% ) | 12 M $ | 30/05/2024 |
Jurgi Camblong active positions
| Companies | Position | Start |
|---|---|---|
| SOPHIA GENETICS SA | Founder | 31/12/2010 |
Swiss Biotech Association
 Swiss Biotech Association Miscellaneous Commercial ServicesCommercial Services Swiss Biotech Association operates as an industry association. The private company is based in Zurich, Switzerland. Michael Altorfer has been the CEO of the Swiss company since 2018. | Director/Board Member | - |
Agora Care SA
 Agora Care SA Information Technology ServicesTechnology Services Agora Care SA provides IT services. The Swiss company was founded in 2021 by Joël Spaltenstein. Osman Ratib has been the CEO of the company since 2021. | Chairman | - |
Former positions of Jurgi Camblong
| Companies | Position | End |
|---|---|---|
GENE PREDICTIS SA
 GENE PREDICTIS SA Miscellaneous Commercial ServicesCommercial Services Part of NIMGenetics Genómica y Medicina SL, Gene Predictis SA engages in the development of diagnostic tools based on genetics that allow treatments for patients. The company is based in Lausanne, Switzerland. The Swiss company was founded in 2004. Goranka Tanackovic has been the CEO of the company since 2011. Gene Predictis was acquired by NIMGenetics Genómica y Medicina SL on February 13, 2023. | Chief Executive Officer | 31/12/2010 |
| University of Geneva | Corporate Officer/Principal | - |
| University of Oxford | Corporate Officer/Principal | - |
Training of Jurgi Camblong
| University of Geneva | Doctorate Degree |
| École Polytechnique Fédérale de Lausanne | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| SOPHIA GENETICS SA | Technology Services |
| Private companies | 3 |
|---|---|
GENE PREDICTIS SA
GENE PREDICTIS SA Miscellaneous Commercial ServicesCommercial Services Part of NIMGenetics Genómica y Medicina SL, Gene Predictis SA engages in the development of diagnostic tools based on genetics that allow treatments for patients. The company is based in Lausanne, Switzerland. The Swiss company was founded in 2004. Goranka Tanackovic has been the CEO of the company since 2011. Gene Predictis was acquired by NIMGenetics Genómica y Medicina SL on February 13, 2023. | Commercial Services |
Swiss Biotech Association
Swiss Biotech Association Miscellaneous Commercial ServicesCommercial Services Swiss Biotech Association operates as an industry association. The private company is based in Zurich, Switzerland. Michael Altorfer has been the CEO of the Swiss company since 2018. | Commercial Services |
Agora Care SA
Agora Care SA Information Technology ServicesTechnology Services Agora Care SA provides IT services. The Swiss company was founded in 2021 by Joël Spaltenstein. Osman Ratib has been the CEO of the company since 2021. | Technology Services |
- Stock Market
- Insiders
- Jurgi Camblong
